From United Therapeutics's results release of 4 ноября 2026 г.; its quarterly report has since been filed.

• Revenue

  Actual

  832,5M $

  +4,1 % y/y ↑
  +6,3 % q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  5,71 $

  -20 % y/y ↓
  -21 % q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  307,8M $

  -21 % y/y ↓
  -7,0 % q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.